Weiguo Ye is COO at GYRE THERAPEUTICS, INC. (GYRE). They have made 8 open-market trades across 1 company since 2026, most recently 2026-06-18.
CIK 0001985496
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| GYRE | 700,000 | $4.3M |
Shares reported on the most recent Form 4, priced at the 2026-06-22 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GYRE | SELL | 2026-06-11 | 2026-06-15 | $6.17 | $17K | +9.4% | +14.0% | +16.4% |
| GYRE | SELL | 2026-06-09 | 2026-06-11 | $6.16 | $129K | +6.8% | +4.6% | +15.0% |
| GYRE | SELL | 2026-06-09 | 2026-06-22 | $6.25 | $69K | +18.4% | -4.0% | +19.7% |
| GYRE | SELL | 2026-06-04 | 2026-06-08 | $6.25 | $219K | +2.5% | +12.3% | +17.3% |
| GYRE | SELL | 2026-05-22 | 2026-05-27 | $6.09 | $46K | +4.1% | +8.3% | +15.3% |
| GYRE | SELL | 2026-05-20 | 2026-05-22 | $6.15 | $137K | +2.9% | +2.7% | +17.4% |
| GYRE | SELL | 2026-05-18 | 2026-05-20 | $6.38 | $59K | -9.6% | -0.2% | +11.9% |
| GYRE | SELL | 2026-05-14 | 2026-05-18 | $6.79 | $195K | -7.5% | -4.4% | +6.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.